Patents by Inventor Meredith JONES

Meredith JONES has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240301106
    Abstract: A method for tailoring mechanical properties of a photopolymer includes providing an active monomer feedstock, adding a sulfur-free chain transfer agent (CTA) to the active monomer feedstock to form a mixture, and curing the mixture under predetermined conditions. The sulfur-free CTA includes a Cobalt(II) complex or a Cobalt(III) complex, the mechanical properties include glass transition temperature, crosslinking density, and/or conversion rate, and a concentration of the sulfur-free CTA is less than 30% of the mixture. The predetermined conditions include intensity, wavelength, and application time of energy from a light source, a cure temperature, and/or the concentration of the sulfur-free CTA in the mixture. The method may further include adding a diluent to the mixture to modify a viscosity of the active monomer feedstock. The diluent may include one of a reactive diluent and a non-reactive diluent, such as methyl methacrylate (MMA) and methacrylate (MA).
    Type: Application
    Filed: February 26, 2024
    Publication date: September 12, 2024
    Applicant: University of Denver
    Inventors: Brady Worrell, Brian Donovan, Nicholas Bagnall, Meredith Jones
  • Patent number: 11498949
    Abstract: High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: November 15, 2022
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Sanjay Vasu, Chao Yan Liu, Jeffrey Rogers, Maria Cisneros, Jingqiu Li, Henry Chiou, Meredith Jones
  • Publication number: 20190077841
    Abstract: High-yield mammalian transient expression systems can include a cell culture media (particularly serum free, non-animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
    Type: Application
    Filed: July 26, 2018
    Publication date: March 14, 2019
    Inventors: Sanjay VASU, Chao Yan LIU, Jeffrey ROGERS, Maria CISNEROS, Jingqiu LI, Henry CHIOU, Meredith JONES
  • Patent number: 10066000
    Abstract: High-Yield mammalian transient expression systems can include a cell culture media (particularly serum free, non animal derived, and/or chemically defined media) for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). Cells containing such introduced materials can then be cultured in the cell culture media. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly mammalian cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells). The invention also relates to compositions and kits useful for culturing and transforming/transfecting cells.
    Type: Grant
    Filed: May 2, 2013
    Date of Patent: September 4, 2018
    Assignee: Life Technologies Corporation
    Inventors: Sanjay Vasu, Henry Chiou, Jeffrey Rogers, Maria Isabel Cisneros, Jingqiu Li, Chao Yan Liu, Meredith Jones
  • Publication number: 20130316400
    Abstract: The present invention is directed generally to cell culture media (particularly serum free, non animal derived, and/or chemically defined media) which are useful for introducing macromolecules and compounds (e.g., nucleic acid molecules) into cells (e.g., eukaryotic cells). According to the invention, such introduction can take place in the presence of said medium. Cells containing such introduced materials can then be cultured in the medium and the effect of the introduced materials on the cells can be measured or determined. In particular, the invention allows introduction of nucleic acid molecules (e.g., vectors) into cells (particularly eukaryotic cells) and expression of proteins encoded by the nucleic acid molecules in the cells. The invention obviates the need to change the cell culture medium each time a different procedure is performed with the cells (e.g., culturing cells vs. transfecting cells).
    Type: Application
    Filed: May 2, 2013
    Publication date: November 28, 2013
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Sanjay VASU, Henry CHIOU, Jeffrey ROGERS, Maria Isabel CISNEROS, Jingqiu LI, Chao Yan LIU, Meredith JONES